AEON insider trading — Aeon Biopharma, Inc.
Over the last 90 days, insiders at Aeon Biopharma, Inc. (AEON) made 1 open-market purchase worth $243K and 0 open-market sales worth $0, making them net buyers by $243K. The largest purchase was by Lynch Timothy P (10% Owner), who bought 1,150,000 shares for $243K on Aug 19, 2026.
Updated Oct 16, 2026.
Recent AEON insider transactions
Every Form 4 filed by Aeon Biopharma, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 19, 2026 | Lynch Timothy P | 10% Owner | P · Purchase | Direct | 1,150,000 | $0.21 | $243K | Form 4 |
AEON insider trading FAQ
Are insiders buying AEON stock?
Yes. In the last 90 days, Aeon Biopharma, Inc. insiders made 1 open-market purchase totaling $243K, and no open-market sales. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading AEON?
Recent buyers: Lynch Timothy P.
Where does AEON insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.